The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappa B inhibitor that impairs osteoclastogenesis
Nadia Rucci, Anna Rufo, Marina Alamanou, Mattia Capulli, Andrea Del Fattore, Emma Åhrman, Daria Capece, Valeria Iansante, Francesca Zazzeroni, Edoardo Alesse, Dick Heinegård, Anna Teti
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review